Anti-VEGF therapy (unspecified agent)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-VEGF therapy (unspecified agent), covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Anti-VEGF Therapy for Acute Thyroid Eye Disease [Phase 2]